Print overview

June 30, 2017

Bayer Aktiengesellschaft: Bayer expects negative earnings impact from its Brazilian Crop Science business

February 08, 2017

Bayer Aktiengesellschaft: Phase III COMPASS study with Bayer's Rivaroxaban in Patients with Coronary or Peripheral Artery Disease Shows Overwhelming Efficacy and Meets Primary Endpoint Early

November 15, 2016

Bayer Aktiengesellschaft: Bayer to issue mandatory convertible notes

September 14, 2016

Bayer Aktiengesellschaft: Bayer and Monsanto to Create a Global Leader in Agriculture

September 06, 2016

Bayer Aktiengesellschaft: Negotiations regarding Monsanto acquisition advance